New PD-L1 inhibitors in non-small cell lung cancer – impact of atezolizumab

por Seetharamu, Nagashree, Preeshagul, Isabel R, Sullivan, Kevin M
Publicado 2017

Optimizing Tissue Use: A Step-wise Approach to Diagnosing Squamous Cell Lung Carcinoma on Small Biopsies

por Olazagasti, Coral, Preeshagul, Isabel, Aziz, Mohamed, Seetharamu, Nagashree
Publicado 2020

Simple parameters to solve a complex issue: predicting response to checkpoint inhibitor therapy in lung cancer

por Newman, James, Preeshagul, Isabel, Kohn, Nina, Devoe, Craig, Seetharamu, Nagashree
Publicado 2020

Potential biomarkers for predicting outcomes in CABG cardiothoracic surgeries

por Preeshagul, Isabel, Gharbaran, Rajendra, Jeong, Kyung Hwa, Abdel-Razek, Ahmed, Lee, Leonard Y, Elman, Elie, Suh, K Stephen
Publicado 2013

Optimizing adjuvant therapy in EGFR-mutated non-small cell lung cancer

por Shepherd, Annemarie F., Preeshagul, Isabel R., Shaverdian, Narek, Wu, Abraham J., Gelblum, Daphna Y., Gomez, Daniel R., Rimner, Andreas, Simone, Charles B.
Publicado 2020

Evaluating of HPV–DNA ISH as an adjunct to p16 testing in oropharyngeal cancer

por Chi, Jeffrey, Preeshagul, Isabel R, Sheikh-Fayyaz, Silvat, Teckie, Sewit, Kohn, Nina, Ziemba, Yonah, Laser, Alice, Frank, Douglas, Ghaly, Maged, Kamdar, Dev, Kraus, Dennis, Paul, Doru, Seetharamu, Nagashree
Publicado 2020

Clinical and Genomic Features of Response and Toxicity to Sotorasib in a Real-World Cohort of Patients With Advanced KRAS G12C-Mutant Non–Small Cell Lung Cancer

por Thummalapalli, Rohit, Bernstein, Ezra, Herzberg, Benjamin, Li, Bob T., Iqbal, Afsheen, Preeshagul, Isabel, Santini, Fernando C., Eng, Juliana, Ladanyi, Marc, Yang, Soo-Ryum, Shen, Ronglai, Lito, Piro, Riely, Gregory J., Sabari, Joshua K., Arbour, Kathryn C.
Publicado 2023

Stage IV Lung Carcinoids: Spectrum and Evolution of Proliferation Rate, Focusing on Variants with Elevated Proliferation Indices

por Rekhtman, Natasha, Desmeules, Patrice, Litvak, Anna M., Pietanza, Maria C., Santos-Zabala, Maria Lauren, Ni, Ai, Montecalvo, Joseph, Chang, Jason C., Beras, Amanda, Preeshagul, Isabel R., Sabari, Joshua K., Rudin, Charles M., Ladanyi, Marc, Klimstra, David S., Travis, William D., Lai, Wei-Chu
Publicado 2019

Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: a cohort study

por Elkrief, Arielle, Alessi, Joao M Victor, Ricciuti, Biagio, Brown, Samantha, Rizvi, Hira, Preeshagul, Isabel R, Wang, Xinan, Pecci, Federica, Di Federico, Alessandro, Lamberti, Giuseppe, Egger, Jacklynn V, Chaft, Jamie E, Rudin, Charles M, Riely, Gregory J, Kris, Mark G, Ladanyi, Marc, Chen, Yuan, Hellmann, Matthew D, Shen, Ronglai, Awad, Mark M, Schoenfeld, Adam J
Publicado 2023